Poetting Sierk 4

What Happened
Sierk Poetting, Chief Operating Officer of BioNTech SE (BNTX), sold 50,000 ordinary shares on April 22, 2026. The shares were disposed at $110.56 per share for a total proceeds of $5,527,960. The Form 4 lists the disposition as a sale (code S) and indicates the shares are held by Tofino GmbH; Poetting is the sole shareholder of Tofino and may be deemed to beneficially own those shares. This was a sale (not a purchase or option exercise), which is often routine and not necessarily a signal of changed company outlook.

Key Details

• Transaction date and price: 2026-04-22 — 50,000 shares at $110.56 each. Total = $5,527,960.
• Transaction type/code: Sale (Form 4 code S); described as open market or private sale.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: F1 — ordinary shares are held by Tofino GmbH; Poetting is sole shareholder and may be deemed beneficial owner.
• Filing timeliness: Report filed 2026-04-23 (filed one day after the transaction).

Context
Insider sales can reflect many reasons (liquidity, portfolio rebalancing, taxes) and are not by themselves proof of negative sentiment. Purchases typically draw more attention as potential bullish signals. For full context, retail investors may want to review recent Form 4s for patterns in insider activity and check reported post-transaction holdings in the complete filing.